The National Primary Health Care Development Agency (NPHCDA) has received 10,000 doses of the JYNNEOS vaccine to enhance Nigeria’s response to mpox.
On Tuesday in Abuja, Muyi Aina, the executive director of NPHCDA, expressed gratitude for the vaccine donation from the U.S. government. He emphasized that this contribution represents more than just the provision of medical supplies.
JYNNEOS is a third-generation vaccine approved for the prevention of smallpox and mpox. The Advisory Committee on Immunisation Practices (ACIP) has recommended its use for individuals at risk of orthopoxvirus infections, including mpox.
Since the outbreak of mpox in 2022, JYNNEOS has been the primary vaccine used in the U.S. It is based on the live attenuated Modified Vaccinia Ankara (MVA) virus, which does not replicate efficiently in humans.
Aina thanked the U.S. government, noting that the donation underscores the strength of international cooperation in addressing global health challenges. He also highlighted that this gesture reinforces the strong relationship between Nigeria and the United States, demonstrating their mutual dedication to global health security.
“Nigeria experienced a significant outbreak of mpox in 2022, but the recent resurgence of cases has underscored the virus’s ongoing threat,” he said.
He said the NPHCDA was committed to ensuring the vaccines were distributed equitably and efficiently to those at highest risk.
“The strategy will prioritise frontline workers, individuals with close contact with confirmed mpox cases, and vulnerable populations,” he said.
He said vaccination was just one aspect of a comprehensive approach to combating Mpox.
According to him, public awareness is also a critical component of the strategy, with plans to intensify efforts to educate the public about mpox, its symptoms, transmission routes, and preventive measures.
He called for the full cooperation of the press, including print, electronic, and new media, in empowering citizens with knowledge to reduce the risk of transmission and promote early reporting of suspected cases.
